Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to -0.26%.

  • CG Oncology's Return on Capital Employed fell 9.00% to -0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.26%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of -0.25% for FY2024, which is N/A change from last year.
  • Latest data reveals that CG Oncology reported Return on Capital Employed of -0.26% as of Q3 2025, which was down 14.40% from -0.23% recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Return on Capital Employed peaked at -0.15% during Q2 2024, and registered a low of -0.26% during Q3 2025.
  • Its 2-year average for Return on Capital Employed is -0.19%, with a median of -0.18% in 2024.
  • Data for CG Oncology's Return on Capital Employed shows a maximum YoY declined of 9bps (in 2025) over the last 5 years.
  • CG Oncology's Return on Capital Employed (Quarterly) stood at -0.18% in 2024, then declined by 9bps to -0.26% in 2025.
  • Its Return on Capital Employed was -0.26% in Q3 2025, compared to -0.23% in Q2 2025 and -0.19% in Q1 2025.